,10,23,27,30,31 A child with HME in the context of PIK3CA-related overgrowth syndrome had reduced seizures and improved cognitive engagement at school following targeted treatment with miransertib (ARQ 092), an orally available AKT inhibitor.134. The gene discussed is PIK3CA; the disease is overgrowth syndrome.